Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inhaled nitric oxide usage in preterm infants in the NICHD neonatal research network: inter-site variation and propensity evaluation

Subjects

Abstract

Objective:

The use of inhaled nitric oxide (iNO) in preterm infants remains controversial. In October 2010, a National Institutes of Health consensus development conference cautioned against use of iNO in preterm infants. This study aims (1) to determine the prevalence and variability in use of iNO in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NICHD NRN) before and after the consensus conference and (2) separately, to examine associations between iNO use and severe bronchopulmonary dysplasia (BPD) or death.

Study design:

The NICHD NRN Generic Database collects data including iNO use on very preterm infants. A total of 13 centers contributed data across the time period 2008 to 2011. Infants exposed or not to iNO were compared using logistic regression, which included factors related to risk as well as their likelihood of being exposed to iNO.

Result:

A total of 4885 infants were assessed between 2008 and 2011; 128 (2.6%) received iNO before day 7, 140 (2.9%) between day 7 and 28, and 47 (1.0%) at >28 days. Center-specific iNO use during 2008 to 2010 ranged from 21.9 to 0.4%; 12 of 13 sites reduced usage and overall NRN iNO usage decreased from 4.6 to 1.6% (P<0.001) in 2011. The use of iNO started between day 7 and day 14 was more prevalent among younger infants with more severe courses in week 1 and associated with increased risk of severe BPD or death (odds ratio 2.24; 95% confidence interval 1.23 to 4.07).

Conclusion:

The variability and total use of iNO decreased in 2011 compared with 2008 to 2010. iNO administration started at day 7 was associated with more severe outcomes compared with infants without iNO exposure.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide for term and near term infants for hypoxic respiratory failure. N Eng J Med 1997; 336: 597–604.

    Article  Google Scholar 

  2. Finer NN, Barrington KJ . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006; ((4)): CD000399.

  3. Truog WE, Castor CA, Sheffield MJ . Neonatal nitric oxide use: predictors of response and financial implications. J Perinatol 2003; 23 (2): 128–132.

    Article  CAS  Google Scholar 

  4. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P . Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349 (22): 2099–2107.

    Article  CAS  Google Scholar 

  5. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355 (4): 343–353.

    Article  CAS  Google Scholar 

  6. Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK et al. Inhaled nitric oxide for premature infants with severe Respiratory Failure. N Engl J Med 2005; 353 (1): 13–22.

    Article  CAS  Google Scholar 

  7. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 354–364.

    Article  CAS  Google Scholar 

  8. Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D et al. EUNO Study Group. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a RCT. Lancet 2010; 376: 346–354.

    Article  CAS  Google Scholar 

  9. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD . Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med 2005; 353 (1): 23–32.

    Article  CAS  Google Scholar 

  10. Patrianakos-Hoobler AI, Marks JD, Msall ME, Huo D, Schreiber MD . Safety and efficacy of inhaled nitric oxide treatment for premature infants with respiratory distress syndrome: follow-up evaluation at early school age. Acta Paediatr 2011; 100 (4): 524–528.

    Article  Google Scholar 

  11. Hibbs AM, Walsh MC, Martin RJ, Truog WE, Lorch SA, Alessandrini E et al. One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to Prevent) Chronic Lung Disease Trial. J Pediatr 2008; 153 (4): 525.

    Article  CAS  Google Scholar 

  12. Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black DM et al. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics 2009; 124 (5): 1325–1332.

    Article  Google Scholar 

  13. Barrington KJ, Finer NN . Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2007; ((12)): CD000509.

  14. Donohoe PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD et al. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 2011; 355: 413–421.

    Google Scholar 

  15. Askie LM, Ballard RA, Cutter G, Dani C, Elbourne D, Field D et al. Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis. BMC Pediatr 2010; 23: 10–15.

    Google Scholar 

  16. Clark RH, Ursprung RL, Walker MW, Ellsbury DL, Spitzer AR . The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit. J Perinatol 2011; 30 (12): 800–804.

    Article  Google Scholar 

  17. Padula MA, Grover TR, Brozanski B, Zaniletti I, Nelin LD, Asselin JM et al. Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at &lt;32 weeks’ gestation. J Perinatol 2013; 33: 877–881.

    Article  CAS  Google Scholar 

  18. Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D et al. NIH Consensus Developmental Conference Statement: Inhaled nitric oxide therapy for premature infants. Pediatrics 2011; 127: 363–369.

    Article  Google Scholar 

  19. Braitman L, Rosenbaum P . Rare outcomes, common treatment: analytic strategies using propensity scores. Annals Internal Med 2002; 137 (8): 693–695.

    Article  Google Scholar 

  20. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305–1311.

    Article  Google Scholar 

  21. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al. National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353–1360.

    Article  Google Scholar 

  22. Rosenbaum PR, Rubin DB . The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41.

    Article  Google Scholar 

  23. D’Agostino RB Jr . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med 1998; 17: 2265–2281.

    Article  Google Scholar 

  24. Freeman VA . Very Low Birth Weight Babies Delivered at Facilities for high-Risk Neonates: A Review of Title V National Performance Measure 17. University of North Carolina at Chapel Hill, Cecil G. Sheps Center for Health Services Research: Chapel Hill, NC, 2010.

    Google Scholar 

  25. Stenger M, Slaughter J, Kelleher K, Shepherd E, Klebanoff M, Reagan P et al. Hospital variation in nitric oxide use for premature infants. Pediatrics 2012; 129: 945–951.

    Article  Google Scholar 

  26. Peliowski A and the Canadian Paediatric Society, Fetus and Newborn Committee. Inhaled nitric oxide use in newborns. Pediatr Child Health 2012; 17: 95–97.

    Article  Google Scholar 

  27. Kumar P and the Committee the Fetus and Newborn. Use of inhaled nitric oxide in preterm infants. Pediatrics 2014; 133: 167–170.

    Article  Google Scholar 

  28. Concato J . Study design and ‘evidence’ in patient-oriented research. Am J Respir Crit Care Med 2013; 187: 1167–1172.

    Article  Google Scholar 

  29. Albert RK . ‘Lies, damned lies…’ and observational studies in comparative effectiveness research. Am J Respir Crit Care Med 2013; 187: 1173–1177.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to W E Truog.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Truog, W., Nelin, L., Das, A. et al. Inhaled nitric oxide usage in preterm infants in the NICHD neonatal research network: inter-site variation and propensity evaluation. J Perinatol 34, 842–846 (2014). https://doi.org/10.1038/jp.2014.105

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.105

This article is cited by

Search

Quick links